Am I reading it right that this means threatment without OPT was actually more effective?:
Mean change in BCVA at week 12 compared to baseline was 5.9 letters for OPT-302 combination therapy and was similar in the Eylea control group at 6.1 letters. 52% of patients in the OPT-302 combination and 60% of patients in the Eylea control group gained ≥5 letters
Ann: Opthea Reports Positive Ph2a Trial Results of OPT-302 in DME, page-3
-
- There are more pages in this discussion • 122 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
47.0¢ |
Change
0.025(5.62%) |
Mkt cap ! $578.6M | |||
| Open | High | Low | Value | Volume |
| 44.0¢ | 47.0¢ | 42.5¢ | $1.327M | 2.960M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 63945 | 46.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 47.0¢ | 88685 | 4 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| OPT (ASX) Chart |